Bacterial CipB is an exogenous receptor to drive the mitophagy-TFEB axis and promote pathogenesis
Journal of Cell Biology · 2026
DOI: 10.1083/jcb.202503028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2026. Verfasst von Shuai Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, College of Biomedicine and Health, Huazhong Agricultural U…. Hauptthemen laut MEDLINE: Mitophagy, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Bacterial Proteins. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Science Fund for Excellent Young Scholars, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mitophagy transports mitochondria to lysosomes for degradation to maintain energy homeostasis, inflammation, and immunity. Here, we identify CipB, a type III secretion system (T3SS) effector from Chromobacterium violaceum, as a novel exogenous mitophagy receptor. CipB targets mitochondria by the mitochondrial protein TUFM and recruits autophagosomes via its LC3-interacting region (LIR) motifs. This process initiates the mitophagy-TFEB axis, triggering TFEB nuclear translocation and suppression of proinflammatory cytokines, thereby promoting bacterial survival and pathogenesis. CipB represents a conserved family of T3SS effectors employed by diverse pathogens to manipulate host mitophagy. Using a mouse model, CipB’s mitophagy receptor function is critical for C. violaceum colonization in the liver and spleen, underscoring its role in bacterial virulence. This study reveals a novel mechanism by which bacterial pathogens exploit host mitophagy to suppress immune responses, defining CipB as a paradigm for exogenous mitophagy receptors. These findings advance our understanding of pathogen–host interactions and highlight the mitophagy-TFEB axis as a potential signaling pathway against bacterial infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, College of Biomedicine and Health, Huazhong Agricultural University , Wuhan, China.
- Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- Institute of Infection and Immunity, Taihe Hospital, Hubei University of Medicine , Shiyan, China.
ORCID-Profile: Shuai Liu, Lina Ma, Ruiqi Lv, Liangting Guo, Xing Pan, Shan Li
Förderung
- National Key Research and Development Program of China
- National Science Fund for Excellent Young Scholars
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
- Shiyan Innovation and Development Joint Foundation of China
- SUSTech
Zitieren
APA
Liu, S., Ma, L., Lv, R., Guo, L., Pan, X., Hu, S., & Li, S. (2026). Bacterial CipB is an exogenous receptor to drive the mitophagy-TFEB axis and promote pathogenesis. Journal of Cell Biology. https://doi.org/10.1083/jcb.202503028
Vancouver
Liu S, Ma L, Lv R, Guo L, Pan X, Hu S, et al. Bacterial CipB is an exogenous receptor to drive the mitophagy-TFEB axis and promote pathogenesis. Journal of Cell Biology. 2026. doi:10.1083/jcb.202503028
BibTeX
@article{Liu2026,
author = {Liu, Shuai and Ma, Lina and Lv, Ruiqi and Guo, Liangting and Pan, Xing and Hu, Shufan and Li, Shan},
title = {Bacterial CipB is an exogenous receptor to drive the mitophagy-TFEB axis and promote pathogenesis},
journal = {Journal of Cell Biology},
year = {2026},
doi = {10.1083/jcb.202503028}
}
EUVIMED